Literature DB >> 12065543

Cytokines induce indoleamine 2,3-dioxygenase expression in human atheroma-asociated cells: implications for persistent Chlamydophila pneumoniae infection.

Jessica B Sakash1, Gerald I Byrne, Andrew Lichtman, Peter Libby.   

Abstract

This study shows that vascular smooth muscle cells express significantly higher levels of gamma interferon-inducible indoleamine 2,3-dioxygenase (IDO) activity than endothelium or mononuclear cells. Since IDO activity is linked to persistent Chlamydophila pneumoniae infection, our results suggest that smooth muscle cells may be an important reservoir of that organism in atherosclerosis.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12065543      PMCID： PMC128116          DOI： 10.1128/IAI.70.7.3959-3961.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  34 in total

Review 1.  Interactions of Chlamydia pneumoniae with human endothelial cells.

Authors:  J T Summersgill; R E Molestina; R D Miller; J A Ramirez
Journal:  J Infect Dis       Date:  2000-06       Impact factor: 5.226

2.  Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2, 3-dioxygenase activity.

Authors:  L G Pantoja; R D Miller; J A Ramirez; R E Molestina; J T Summersgill
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

3.  Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon.

Authors:  L G Pantoja; R D Miller; J A Ramirez; R E Molestina; J T Summersgill
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Analysis of transcription factors regulating induction of indoleamine 2,3-dioxygenase by IFN-gamma.

Authors:  M X Du; W D Sotero-Esteva; M W Taylor
Journal:  J Interferon Cytokine Res       Date:  2000-02       Impact factor: 2.607

6.  Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells.

Authors:  T A Babcock; J M Carlin
Journal:  Cytokine       Date:  2000-06       Impact factor: 3.861

Review 7.  The role of adaptive immunity in atherosclerosis.

Authors:  G K Hansson; X Zhou; E Törnquist; G Paulsson
Journal:  Ann N Y Acad Sci       Date:  2000-05       Impact factor: 5.691

Review 8.  The role of inflammation and infection in coronary artery disease.

Authors:  A E Becker; O J de Boer; A C van Der Wal
Journal:  Annu Rev Med       Date:  2001       Impact factor: 13.739

Review 9.  Potential infectious etiologies of atherosclerosis: a multifactorial perspective.

Authors:  S O'Connor; C Taylor; L A Campbell; S Epstein; P Libby
Journal:  Emerg Infect Dis       Date:  2001 Sep-Oct       Impact factor: 6.883

10.  Inhibition of T cell proliferation by macrophage tryptophan catabolism.

Authors:  D H Munn; E Shafizadeh; J T Attwood; I Bondarev; A Pashine; A L Mellor
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307
View more
  16 in total

Review 1.  Chlamydial persistence: beyond the biphasic paradigm.

Authors:  Richard J Hogan; Sarah A Mathews; Sanghamitra Mukhopadhyay; James T Summersgill; Peter Timms
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

2.  A functional serotonin transporter gene polymorphism and depressive effects associated with interferon-alpha treatment.

Authors:  Amira Pierucci-Lagha; Jonathan Covault; Herbert L Bonkovsky; Richard Feinn; Christine Abreu; Richard K Sterling; Robert J Fontana; Henry R Kranzler
Journal:  Psychosomatics       Date:  2010 Mar-Apr       Impact factor: 2.386

Review 3.  Immune effector mechanisms implicated in atherosclerosis: from mice to humans.

Authors:  Peter Libby; Andrew H Lichtman; Göran K Hansson
Journal:  Immunity       Date:  2013-06-27       Impact factor: 31.745

4.  Kynurenine is an endothelium-derived relaxing factor produced during inflammation.

Authors:  Yutang Wang; Hanzhong Liu; Gavin McKenzie; Paul K Witting; Johannes-Peter Stasch; Michael Hahn; Dechaboon Changsirivathanathamrong; Ben J Wu; Helen J Ball; Shane R Thomas; Vimal Kapoor; David S Celermajer; Andrew L Mellor; John F Keaney; Nicholas H Hunt; Roland Stocker
Journal:  Nat Med       Date:  2010-02-28       Impact factor: 53.440

5.  Activation of NAD(P)H oxidase by tryptophan-derived 3-hydroxykynurenine accelerates endothelial apoptosis and dysfunction in vivo.

Authors:  Qiongxin Wang; Miao Zhang; Ye Ding; Qilong Wang; Wencheng Zhang; Ping Song; Ming-Hui Zou
Journal:  Circ Res       Date:  2013-11-26       Impact factor: 17.367

6.  Mouse pancreatic islets are resistant to indoleamine 2,3 dioxygenase-induced general control nonderepressible-2 kinase stress pathway and maintain normal viability and function.

Authors:  Reza B Jalili; Farshad Forouzandeh; Alireza Moeenrezakhanlou; Gina R Rayat; Ray V Rajotte; Hasan Uludag; Aziz Ghahary
Journal:  Am J Pathol       Date:  2008-12-12       Impact factor: 4.307

7.  PEG-rIL-10 treatment decreases FoxP3(+) Tregs despite upregulation of intratumoral IDO.

Authors:  Ivan H Chan; Victoria Wu; Melissa Bilardello; Brett Jorgenson; Harminder Bal; Scott McCauley; Peter Van Vlasselaer; John B Mumm
Journal:  Oncoimmunology       Date:  2016-06-27       Impact factor: 8.110

8.  Potential role of indoleamine 2,3-dioxygenase in primary biliary cirrhosis.

Authors:  Kashif Asghar; John Brain; Jeremy M Palmer; Stephen Douglass; Fatmah M A Naemi; Graeme O'Boyle; John Kirby; Simi Ali
Journal:  Oncol Lett       Date:  2017-08-28       Impact factor: 2.967

Review 9.  A dialogue between the immune system and brain, spoken in the language of serotonin.

Authors:  Nicole L Baganz; Randy D Blakely
Journal:  ACS Chem Neurosci       Date:  2012-12-07       Impact factor: 4.418

10.  Kynurenine pathway and white matter microstructure in bipolar disorder.

Authors:  Sara Poletti; Aye Mu Myint; Gregor Schüetze; Irene Bollettini; Elena Mazza; Doris Grillitsch; Clara Locatelli; Markus Schwarz; Cristina Colombo; Francesco Benedetti
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-09-12       Impact factor: 5.270
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.